Menu
Puma is a consultant radiation oncologist at Westmead Hospital, A/Prof at The University of Sydney and graduate of the Australian Institute of Company Directors. Her clinical and research specialities are head and neck, skin, lower gastrointestinal and haematological malignancies. Puma has served on the TROG Scientific Committee, Publications Committee (chair), RANZR Radiation Oncology Research Committee and Cancer Symptom Control Trials group’s Management Advisory Committee, and is currently chair of the Board of Head and Neck Cancer Australia. She is Facilitator of the annual RANZCR / TROG SMART workshop and the ACORD concept /protocol development workshops.
Trevor is a consultant Radiation Oncologist and immediate past Director of Radiation Oncology at Peter MacCallum Cancer Centre. He is previous President/Board Chair of TROG and has chaired the TROG Scientific Committee. Trevor is also a Board Director of AGITG.
Professor Leong is an active clinician researcher who is involved in both translational research programs as well as clinical research. He is internationally recognized as a leader in the management and research of gastrointestinal cancers.
Hien serves as a consultant radiation oncologist at the Royal Adelaide Hospital, holding the position of Head of Research. Additionally, he provides patient care at the ICON cancer centre. He currently leads as the chairperson for the TROG Scientific Committee and is a council member of the RANZCR Faculty of Radiation Oncology. Hien’s expertise lies in leveraging advanced technologies within both clinical practice and research, which is crucial given the rapid advancements in radiation oncology. Collaborating with the South Australian team, Hien has dedicated several years to establishing the region’s inaugural particle therapy facility.
Tim works as a Special Advisor for HoustonKemp Economists and the Principal at Walbrook Partners. He is an experienced and well-respected rail safety expert. Tim contributes his vast understanding of regulation to the TROG Board.
Andrew is an experienced in-house lawyer and is currently General Counsel at Pacific National, Australia’s largest private rail freight operator. Andrew is energised by working with people, improving processes and generating valuable outcomes. He recognises the importance and value of diversity of thought and brings this to his position on the TROG Board. He is a current member of the Finance Audit & Risk Management Committee
Dr Gerry Adams is a UK trained clinical oncologist who arrived in Australia in 2010. After completing his Fellowship he has worked as a consultant in regional Queensland for 9 years and was involved in various positions within the Royal Australian and New Zealand College of Radiologists (RANZCR) during that time. For the last 3 years he has been a member of RANZCR Council and Chair of the Economics and Work Force Committee (EWC). As RANZCR Dean Gerry’s position on the Board of Directors of TROG will help maintain the important strategic links and shared values of our two organisations. Gerry has a particular interest in improving access to quality radiation therapy in regional areas.
Annette is a Professor of Medical Physics and Director, Institute of Medical Physics at the University of Sydney (NSW) and has more than 20 years of hospital-based clinical experience. She has been involved in TROG Cancer Research activities for over 15 years including members of the New Techniques and Technologies Committee, the TROG Scientific Committee, TROG Radiation Therapy Quality Assurance team, a TROG representative on the Global Harmonisation Group as well as being a member of multiple Trial Management Committees.
Murray is a Deputy Chair of Cancer Voices NSW and a Health Consumer NSW Board member. He has previously volunteered with Cancer Council NSW, drawing on his professional life experience in the NSW public sector around policy and advocacy. His personal cancer experiences include the death of his long term partner from pancreatic cancer in 2007, and successful surgical intervention for prostate cancer in 2009.
Sue is an experienced international executive in the pharmaceutical industry. She has worked in research as a health economist and in outcomes research in various cancers, and currently consults to the pharmaceutical industry. Sue has previously held Board positions internationally and is passionate about quality care for cancer patients. She is a current member of the Finance Audit & Risk Management Committee.
Melissa is a radiation oncologist practicing in Christchurch, having completed her RANZCR fellowship training in Australia (Prince of Wales Hospital, Sydney) and New Zealand. She has an interest in radiation treatment for brain, breast and skin cancers. Melissa has been involved in recruiting patients to TROG trials since she was a registrar and has been an active member of the TROG urology and breast working parties.
Georgia is a senior research fellow at Curtin University and is Co-Lead for the Cancer Domain in the Curtin Health innovation Research Institute. Her current research program is focused on patients and carers psychosocial and information needs, cancer survivorship and research into radiation therapy.
Georgia is the WA Board Director for ASMIRT and Board member for COGNO. In joining the TROG Board she aims to help increase radiation therapists involvement in leading and conducting research.
For over 30 years, Trans-Tasman Radiation Oncology Group has been dedicated to improving the way radiation medicine is delivered to cancer patients with ongoing scientific research, clinical trials, and cutting-edge technology.
Latest News
Keep up to date with TROG news, subscribe to our community newsletter.
ABN: 45 132 672 292